SQA
ARRY

Simon Quick Advisors’s Array Biopharma Inc ARRY Stock Holding History

Simon Quick Advisors’s Portfolio ARRY Stock Details ARRY Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2019
Q2 		– Sell
-15,885
Closed -$387K – 616
2019
Q1 		$387K Sell
15,885
-73
-0.5% -$1.52K 0.16% 45
2018
Q4 		$227K Hold
15,958
– – 0.08% 65
2018
Q3 		$243K Hold
15,958
– – 0.1% 60
2018
Q2 		$267K Hold
15,958
– – 0.11% 57
2018
Q1 		$260K Hold
15,958
– – 0.11% 68
2017
Q4 		$236K Buy
+15,958
New +$182K 0.11% 84

Other funds holding ARRY

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
RG
Redmile Group San Francisco, California $1.51B AUM 164.17% 1-Year Est. Return
FCM
Farallon Capital Management San Francisco, California $17.5B AUM 50.95% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
DKCM
Davidson Kempner Capital Management New York $7.33B AUM 56.47% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
Franklin Resources
Franklin Resources San Mateo, California $408B AUM 30.18% 1-Year Est. Return
Citadel Advisors
Citadel Advisors Miami, Florida $618B AUM 30.34% 1-Year Est. Return

Simon Quick Advisors's ARRY Position: Q2 2019 in Review

Simon Quick Advisors sold out of Array Biopharma Inc (ARRY) in Q2 2019, closing a stake of 15,885 shares — an estimated $387K sold.

Simon Quick Advisors first reported a position in ARRY in Q4 2017 and held it in 6 quarters. The position peaked at $387K in Q1 2019. 318 funds tracked by Wall St. Rank hold ARRY as of Q2 2019.

  • Simon Quick Advisors reported no remaining Array Biopharma Inc position as of Q2 2019 after selling out during the quarter.
  • Simon Quick Advisors sold 15,885 Array Biopharma Inc shares in Q2 2019, an estimated $387K.
  • Simon Quick Advisors first reported a position in Array Biopharma Inc in Q4 2017 and held it in 6 quarters.
  • Simon Quick Advisors's Array Biopharma Inc position peaked at $387K in Q1 2019.
  • 318 funds tracked by Wall St. Rank held Array Biopharma Inc as of Q2 2019.

Based on Simon Quick Advisors's 13F filing for Q2 2019, filed 5 Aug 2019.